Johnson & Johnson Vision Collaborates with Menicon With Contact Lenses To Manage Myopia in Children

Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, announced a global strategic collaboration with Menicon, a leading manufacturer of innovative contact lenses. The collaboration is part of a broader commitment from Johnson & Johnson Vision to lead with science and help reshape the future of myopia – and bring forward a novel portfolio of products and services to manage the progression of myopia in children.

Myopia is sometimes called ‘nearsightedness’ but it is much more. It is a chronic and progressive disease that poses the biggest eye health threat of the 21st Century1. Children ages 12 and younger are among the most vulnerable2, and half of the world’s population is projected to be myopic by 2050 with one billion people expected to have high myopia3. Myopia may be caused by both environmental and genetic factors that may increase the risk of retinal detachment, degeneration, cataracts, and glaucoma – all of which can lead to visual impairment and blindness4.